Clincosm LogoSign in Get a demo

A Comparative Study of the Air-Q ILA and the ILMA for Ventilation and Intubation

Sponsor
Nova Scotia Health Authority (Other)
Overall Status
Withdrawn
CT.gov ID
NCT01209559
Collaborator
(none)
0
Enrollment
1
Location

Study Details

Study Description

Brief Summary

The objective of this study is to determine if the glottic view obtained with the air-Q Intubating Laryngeal Airway (air-Q ILA, Cookgas LLC®, Mercury Medical®, Clearwater, FL, USA) is better than that obtained with the traditionally used intubating laryngeal mask airway (LMA FastrachTM or ILMA, LMA North America Inc., San Diego, CA). The study will also compare effectiveness of ventilation.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    0 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Study Start Date :
    Jan 1, 2011
    Actual Primary Completion Date :
    Jan 1, 2011
    Actual Study Completion Date :
    Jan 1, 2011

    Arms and Interventions

    Arm Intervention/Treatment
    air-Q Intubating Laryngeal Airway
    LMA FastrachTM or ILMA

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      18 Years and Older
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      No
      Inclusion Criteria:
      • healthy ASA class I and II patients scheduled for elective surgery under general anesthesia requiring the use of the LMA
      Exclusion Criteria:

      • history of acid reflux,

      • a BMI ≥ 40kg.m-2,

      • require endotracheal intubation,

      • have predictors of difficult intubation,

      • not candidates for insertion of an ILMA or LMA, including a mouth opening of less than 2.5 cm,

      • cannot consent to the study

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 QEII Health Sciences Centre Halifax Nova Scotia Canada B3H 2Y9

      Sponsors and Collaborators

      • Nova Scotia Health Authority

      Investigators

      None specified.

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      None provided.
      Responsible Party:
      Orlando Hung, MD FRCPC, Nova Scotia Health Authority
      ClinicalTrials.gov Identifier:
      NCT01209559
      Other Study ID Numbers:
      • CDHA-RS/2011-156
      First Posted:
      Sep 27, 2010
      Last Update Posted:
      Jul 18, 2018
      Last Verified:
      Jul 1, 2018

      Study Results

      No Results Posted as of Jul 18, 2018